Drugs for Lentigines (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 39)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Aminolevulinic acid |
Approved |
Phase 4 |
|
106-60-5 |
137 |
Synonyms:
5 Aminolaevulinate
5 Aminolevulinate
5-ALA
5-Amino-4-oxopentanoate
5-Amino-4-oxo-pentanoate
5-Amino-4-oxopentanoic acid
5-Amino-4-oxo-pentanoic acid
5-Amino-4-oxovalerate
5-Amino-4-oxovaleric acid
5-Aminolaevulinate
5-Aminolaevulinic acid
5-Aminolevulinate
5-Amino-levulinate
5-Aminolevulinic acid
5-Amino-levulinic acid
Acid hydrochloride, aminolevulinic
Acid, aminolevulinic
Acid, Delta-aminolevulinic
|
ácido 5-aminolevulínico
Aladerm
Aminolevulinate
Aminolevulinic acid
Amino-levulinic acid
Aminolevulinic acid hydrochloride
Bertek brand OF aminolevulinic acid hydrochloride
dALA
Delta Aminolevulinic acid
delta-ALA
delta-Aminolevulinate
delta-Aminolevulinic acid
Hydrochloride, aminolevulinic acid
Kerastick
Levulan
δ-ALA
Δ-aminolevulinate
δ-aminolevulinic acid
|
|
2 |
|
Imiquimod |
Approved, Investigational |
Phase 4 |
|
99011-02-6 |
57469 |
Synonyms:
1-Isobutyl-1H-imidazo(4,5-c)quinolin-4-amine
1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline
Aldara
Aldara®|R837|S-26308|Zyclara®
Imiquimod
Imiquimod acetate
|
Imiquimodum
R 837
R-837
S-26308
ZARTRA
Zyclara
|
|
3 |
|
Glycolic acid |
Approved, Investigational |
Phase 4 |
|
79-14-1 |
757 |
Synonyms:
2-Hydroxyacetate
2-Hydroxyacetic acid
2-Hydroxyethanoate
2-Hydroxyethanoic acid
a-Hydroxyacetate
a-Hydroxyacetic acid
alpha-Hydroxyacetate
alpha-Hydroxyacetic acid
Glycocide
Glycolate
GLYCOLIC ACID
Glycolic acid, 1-(14)C-labeled
Glycolic acid, 2-(14)C-labeled
Glycolic acid, calcium salt
Glycolic acid, monoammonium salt
Glycolic acid, monolithium salt
Glycolic acid, monopotassium salt
|
Glycolic acid, monosodium salt
Glycolic acid, potassium salt
Glycollate
Glycollic acid
GlyPure
GlyPure 70
HOCH2COOH
Hydroxyacetate
Hydroxyacetic acid
Hydroxyethanoate
Hydroxyethanoic acid
NSC-166
Potassium glycolate
Sodium glycolate
Α-hydroxyacetate
Α-hydroxyacetic acid
|
|
4 |
|
Photosensitizing Agents |
|
Phase 4 |
|
|
|
5 |
|
Adjuvants, Immunologic |
|
Phase 4 |
|
|
|
6 |
|
interferons |
|
Phase 4 |
|
|
|
7 |
|
Immunologic Factors |
|
Phase 4 |
|
|
|
8 |
|
Keratolytic Agents |
|
Phase 4 |
|
|
|
9 |
|
Fluocinolone acetonide |
Approved, Investigational, Vet_approved |
Phase 2 |
|
67-73-2 |
6215 |
Synonyms:
6alpha,9alpha-difluoro-16alpha-hydroxyprednisolone 16,17-acetonide
6alpha-fluorotriamcinolone acetonide
6α,9α-difluoro-16α-hydroxyprednisolone 16,17-acetonide
6α-fluorotriamcinolone acetonide
acétonide de fluocinolone
acetónido de fluocinolona
CAPEX
Capex®|Iluvien®|Synalar®
DERMA-SMOOTHE/FS
DERMOTIC
FLUOCET
fluocinolon acetonid
FLUOCINOLONE
fluocinolone 16,17-acetonide
Fluocinolone acetonide
|
fluocinoloni acetonidum
FLUONID
FLUOTREX
FS SHAMPOO
ILUVIEN
NSC-92339
RETISERT
SYNALAR
SYNALAR FTE
SYNALAR-C
SYNALAR-HP
SYNALAR-N
SYNANDONE
YUTIQ
|
|
10 |
|
Hydroquinone |
Approved, Investigational |
Phase 2 |
|
123-31-9 |
785 |
Synonyms:
1,4-Benzenediol
1,4-Benzoquinol
1,4-Dihydroxy-benzeen
1,4-Dihydroxybenzen
1,4-Dihydroxybenzene
1,4-Dihydroxy-benzol
1,4-Diidrobenzene
1,4-p-Benzenediol
1,4-Phenylenediol
4-Hydroxyphenol
a-Hydroquinone
alpha-Hydroquinone
Artra
Benzene-1,4-diol
Benzohydroquinone
Benzoquinol
beta-Quinol
Black and white
BLACK AND WHITE BLEACHING CREAM
b-Quinol
CHEMBL537
Dihydroquinone
Dihydroxybenzene
Eldopaque
Eldopaque forte
Eldoquin
Eldoquin forte
Esoterica
Hidroquilaude
Hidroquin
Hidroquinona isdin
Hydrochinon
Hydrochinone
Hydroquinol
Hydroquinole
HYDROQUINONE
Hydroquinone for synthesis
Hydroquinone GR
|
Hydroquinone, copper (1+) salt
Hydroquinone, lead (2+) salt (2:1)
Hydroquinone, monocopper (2+) salt
Hydroquinoue
ICN brand 1 OF hydroquinone
ICN brand 2 OF hydroquinone
ICN brand 3 OF hydroquinone
ICN brand 4 OF hydroquinone
Idrochinone
Licostrata
Lustra
Melanasa
Melanex
Melpaque
Melquin
NCI-C55834
Neostrata HQ
NSC-9247
p-Benzenediol
p-Dihydroquinone
p-Dihydroxybenzene
P-Dioxobenzene
p-Dioxybenzene
Phiaquin
p-Hydroquinone
P-Hydroxybenzene
p-Hydroxyphenol
Plough brand 1 OF hydroquinone
Plough brand 2 OF hydroquinone
p-Phenylenediol
p-Quinol
Quinol
Solaquin
Solaquin forte
Stratus brand 1 OF hydroquinone
Stratus brand 2 OF hydroquinone
Ultraquin
|
|
11 |
|
Isotretinoin |
Approved, Investigational, Nutraceutical |
Phase 2 |
|
302-79-4, 4759-48-2 |
5538 444795 5282379 |
Synonyms:
(13-cis)-Retinoate
(13-CIS)-RETINOIC ACID
(2E,4E,6E,8E)-3,7-DIMETHYL-9-(2,6,6-TRIMETHYL-1-CYCLOHEXENYL)NONA-2,4,6,8-TETRAENOIC ACID
(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoate
(2Z,4E,6E,8E)-3,7-DIMETHYL-9-(2,6,6-TRIMETHYLCYCLOHEX-1-EN-1-YL)NONA-2,4,6,8-TETRAENOIC ACID
(7E,9E,11E,13Z)-Retinoate
(7E,9E,11E,13Z)-RETINOIC ACID
(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate
(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
13 cis Retinoic acid
13 CIS-RETINOIC ACID
13-cis-Retinoate
13-cis-Retinoate,isotretinoin
13-CIS-RETINOIC ACID
13-CIS-VITAMIN A ACID
13-RA
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoate (ecl)
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)
Aberel
ABSORICA
ACCUTANE
Acid, all-trans-retinoic
Acid, beta-all-trans-retinoic
Acid, retinoic
Acid, trans-retinoic
Acid, vitamin a
Acide retinoique
ACIDE RETINOIQUE (FRENCH)
ACIDE RETINOIQUE (FRENCH) (DSL)
ACTICIN
AGN 100335
Airol
Aknefug
Aknoten
all trans Retinoic acid
all trans-Retinoic acid
all-(e)-Retinoate
all-(e)-Retinoic acid
all-trans-beta-Retinoate
all-trans-beta-Retinoic acid
all-trans-b-Retinoate
all-trans-b-Retinoic acid
all-trans-Retinoate
all-trans-Retinoic acid
ALL-TRANS-RETINOIC ACID (ATRA)
all-trans-retinoic acid (ATRA)|Altreno® (0.05% lotion)|Avita® (0.025% gel)|Renova® (0.02% cream)
all-trans-Tretinoin
all-trans-Vitamin a acid
all-trans-Vitamin a1 acid
all-trans-Β-retinoate
all-trans-Β-retinoic acid
ALTRENO
AMNESTEEM
ATRA
Atra-IV
Atralin
Avita
beta all trans Retinoic acid
beta-all-trans-Retinoic acid
beta-Retinoate
beta-Retinoic acid
b-Retinoate
b-Retinoic acid
CIP-isotretinoin
CIS-RA
cis-Retinoate
|
CIS-RETINOIC ACID
CLARAVIS
Dermairol
Eudyna
ISOTRETINOIN
Isotretinoin zinc salt, 13 cis isomer
Isotretinoin zinc salt, 13-cis-isomer
Isotretinoina
Isotretinoína
Isotretinoine
Isotrétinoine
Isotretinoino
Isotretinoinum
ISOTREX
Lsotretinoin
MYORISAN
NEOVITAMIN A ACID
NSC-122758
PAT-001
Potassium salt, tretinoin
Renova
Retin a
Retin-a
Retin-a micro
RETIN-A-MICRO
Retinoate
Retinoic acid
RETINOIC ACID 13-CIS-FORM
Retionic acid
Retisol-a
Ro 1-5488
RO-43780
RO-4-3780
Roaccutan
ROACCUTANE
Roacutan
Salt, tretinoin potassium
Salt, tretinoin sodium
Salt, tretinoin zinc
Sodium salt, tretinoin
Solage
SOTRET
Stieva-a
Stieva-a Forte
Teriosal
trans Retinoic acid
trans-Retinoate
trans-Retinoic acid
Tretin m
Tretinoin
Tretinoin potassium salt
Tretinoin sodium salt
Tretinoin zinc salt
TRETINOIN、ATRA
Tretinoina
Trétinoïne
TRETINOINE (FRENCH)
TRETINOINE (FRENCH) (EINECS)
Tretinoinum
Tretin-X
Tri-Luma
Vesanoid
Vitamin a acid
Vitinoin
ZENATANE
Zinc salt, tretinoin
Β-retinoate
Β-retinoic acid
|
|
12 |
|
Cediranib |
Investigational |
Phase 2 |
|
288383-20-0 |
9933475 |
Synonyms:
4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline
4-(4-FLUORO-2-METHYLINDOL-5-YLOXY)-6-METHOXY-7-[3-(PYRROLIDIN-1-YL)PROPOXY]QUINAZOLINE
AZD 2171
AZD 2171|AZD2171|ZD 2171
AZD-2171
|
CEDIRANIB
RECENTIN
ZD 2171
ZD-2171
|
|
13 |
|
Maleic acid |
Experimental, Investigational |
Phase 2 |
|
110-16-7, 110-17-8 |
444266 444972 |
Synonyms:
(2E)-2-Butenedioate
(2E)-2-Butenedioic acid
(2E)-But-2-enedioate
(2E)-But-2-enedioic acid
(2Z)-2-Butenedioate
(2Z)-2-Butenedioic acid
(2Z)-But-2-enedioate
(2Z)-But-2-enedioic acid
(2Z)-Butene-2-dioate
(2Z)-Butene-2-dioic acid
(e)-2-Butenedioate
(e)-2-Butenedioic acid
(Z)-2-Butenedioate
(Z)-2-Butenedioic acid
(Z)-Butenedioate
(Z)-Butenedioic acid
2-(e)-Butenedioate
2-(e)-Butenedioic acid
2-Butenedioate
2-Butenedioic acid
Allomaleate
Allomaleic acid
Boletate
Boletic acid
cis-1,2-Ethylenedicarboxylate
cis-1,2-Ethylenedicarboxylic acid
cis-2-Butenedioate
cis-2-Butenedioic acid
cis-But-2-enedioate
cis-But-2-enedioic acid
cis-Butenedioate
cis-Butenedioic acid
e297
FC 33
Fumarate
Fumaric acid
Fumaricum acidum
Fumarsaeure
|
Fumarsäure
Furamag
H2Male
Hydrogen maleate
Kyselina maleinova
Lichenate
Lichenic acid
MAE
Mafusol
Maleate
MALEIC ACID
Maleic acid, ammonium salt
Maleic acid, calcium salt
Maleic acid, dipotassium salt
Maleic acid, disodium salt
Maleic acid, iron salt
Maleic acid, monoammonium salt
Maleic acid, monocopper (2+) salt
Maleic acid, monosodium salt
Maleic acid, neodymium salt
Maleic acid, potassium salt
Maleic acid, sodium salt
Maleinic acid
Malenic acid
Malezid CM
Scotchbond multipurpose etchant
Sodium maleate
Toxilate
Toxilic acid
trans-1,2-Ethylenedicarboxylate
trans-1,2-Ethylenedicarboxylic acid
trans-2-Butenedioate
trans-2-Butenedioic acid
trans-But-2-enedioate
trans-But-2-enedioic acid
trans-Butenedioate
trans-Butenedioic acid
|
|
14 |
|
Protein Kinase Inhibitors |
|
Phase 2 |
|
|
|
15 |
|
R04929097 |
|
Phase 2 |
|
|
|
16 |
|
Clobetasol |
Approved, Experimental, Investigational |
|
|
25122-46-7, 25122-41-2 |
2791 5311051 32798 |
Synonyms:
(11b,16b)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
(11beta,16beta)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
(11Β,16β)-21-chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
14-(2-Chloroacetyl)-1-fluoro-17-hydroxy-2,13,15-trimethyl-5-oxotetracyclo[8.7.0.0,.0,]heptadeca-3,6-dien-14-yl propanoic acid
21-CHLORO-9-FLUORO-11BETA,17-DIHYDROXY-16BETA-METHYLPREGNA-1,4-DIENE-3,20-DIONE 17-PROPIONATE
21-CHLORO-9-FLUORO-11Β,17-DIHYDROXY-16Β-METHYLPREGNA-1,4-DIENE-3,20-DIONE 17-PROPIONATE
CCI-4725
CCI-4725|Clobex®|Dermovate®|GR 2/925|Temovate®
CLARELUX
CLOBADERM
Clobecort amex
CLOBETASOL
Clobetasol 17 propionate
CLOBETASOL 17-PROPANOATE
Clobetasol 17-propionate
Clobetasol propionate
CLOBETASOL PROPIONATE (EMOLLIENT)
|
CLOBETASOL PROPIONATE E
Clobetasol propionic acid
Clobetasolum
Clobex
Clofenazon
Cormax
Dermovate
DERMOVATE NN
Embeline
Embeline e
ETRIVEX
GR 2/925
IMPOYZ
OLUX
OLUX E
Temovate
TEMOVATE E
|
|
17 |
|
Framycetin |
Approved, Experimental, Vet_approved |
|
|
1404-04-2, 119-04-0, 3947-65-7 |
413349 8378 |
Synonyms:
2-desoxy-4-O-(2,6-diamino-2,6-didesoxy-α-D-glucopyranosyl)-D-streptamin
4-O-(2,6-diamino-2,6-dideoxy-α-D-glucopyranosyl)-2-deoxy-D-streptamine
Antibiotic 10676
ANTIBIOTIQUE EF 185
Biosol
Bykomycin
Caswell no. 595
Dekamycin V
Endomixin
Fradiomycin
Fradiomycin b
Fradiomycin sulfate
Framicetina
Framycetin
Framycetin sulfate
Framycetine
Framycétine
Framycetinum
Fraquinol
FRM
Kaomycine
Lidamycin Creme
Myacine
Myacyne
Mycifradin
Mycifradin-N
Myciguent
NEAMINE
Nebramycin X
Negamicin
|
Neobiotic
Neobrettin
Neofracin
Neo-Fradin
Neolate
Neo-Mantle Creme
Neomicina
Neomix
NEOMYCIN
Neomycin A
Neomycin b
Neomycin b sulfate
Neomycin palmitate
Neomycin sulfate
Neomycin sulphate
Neomycin trisulfate salt hydrate
NEO-RX
Neo-Rx®|neomycin sulfate
Neosulf
Nivemycin
Palmitate, neomycin
Soframycin
Sulfate, fradiomycin
Sulfate, framycetin
Sulfate, neomycin
Sulfate, neomycin b
Tuttomycin
USAF CB-19
Vonamycin
Vonamycin Powder V
|
|
18 |
|
Petrolatum |
Approved, Investigational |
|
|
8009-03-8 |
|
Synonyms:
Multi-hydrocarbon
Paraffinum album
Paraffinum flavum
Petrolatum
Petrolatum base
Petrolatum, white
Petrolatum,amber
|
Petrolatum,white
Petroleum jelly
Soft paraffin
White petrolatum
White, soft paraffin
Yellow soft paraffin
|
|
19 |
|
Tazarotene |
Approved, Investigational |
|
|
118292-40-3 |
5381 |
Synonyms:
AGN-190168
AGN-190168|Tazorac®|Zorac®
Avage
Fabior
TAZAROTENE
|
Tazarotène
Tazaroteno
Tazarotenum
Tazorac
Zorac
|
|
20 |
|
Lidocaine |
Approved, Vet_approved |
|
|
137-58-6 |
3676 |
Synonyms:
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-2ETN-2MePhAcN
a-Diethylamino-2,6-dimethylacetanilide
ALGRX 3268
ALGRX-3268
ALPHACAINE
alpha-Diethylamino-2,6-dimethylacetanilide
ANESTACON
Astrazeneca brand OF lidocaine
Dalcaine
Dentipatch
Dilocaine
EMBOLEX
IONTOCAINE
Jenapharm brand OF lidocanine hydrochloride
L-Caine
Lidocaina
Lidocaína
LIDOCAINE
Lidocaine carbonate
Lidocaine carbonate (2:1)
Lidocaine hydrocarbonate
Lidocaine hydrochloride
Lidocaine monoacetate
Lidocaine monohydrochloride
|
Lidocaine monohydrochloride, monohydrate
Lidocaine sulfate (1:1)
Lidocainum
LIDOCATON
Lidoderm
LIDOPEN
Lignocaine
LIGNOCAINE HCL
LIGNOSTAB
LMX 4
Novocol brand OF lidocaine hydrochloride
NSC-40030
Octocaine
ORAQIX
Strathmann brand OF lidocaine hydrochloride
VAGISIL
Xylesthesin
Xylocaine
Xylocaine®
Xylocitin
XYLODASE
Xyloneural
XYLOTOX
ZTLIDO
Α-diethylamino-2,6-dimethylacetanilide
|
|
21 |
|
Prilocaine |
Approved |
|
|
721-50-6 |
4906 |
Synonyms:
2-(Propylamino)-O-propionotoluidide
2-Methyl-alpha-propylaminopropionanilide
2-Methyl-a-propylaminopropionanilide
2-Methyl-α-propylaminopropionanilide
alpha-N-Propylamino-2-methylpropionanilide
a-N-Propylamino-2-methylpropionanilide
ASTRA 1512
Astra 1515
Astra brand OF prilocaine hydrochloride
ASTRA-1512
ASTRA-1515
AstraZeneca brand OF prilocaine hydrochloride
Citanest
Citanest octapressin
Citanest Plain
Delvet brand OF prilocaine hydrochloride
Inibsa brand OF prilocaine hydrochloride
L-67
|
N-(2-Methylphenyl)-2-(propylamino)propanamide
NSC-40027
O-Methyl-2-propylaminopropionanilide
O-Methyl-alpha-propylaminopropionanilide
O-Methyl-a-propylaminopropionanilide
O-Methyl-α-propylaminopropionanilide
Parnell brand OF prilocaine hydrochloride
PRILOCAIN
Prilocaina
PRILOCAINE
PRILOCAÏNE
Prilocaine base
Prilocaine hydrochloride
Prilocainum
PRILOTEKAL
Propitocaine
Xylonest
Α-N-propylamino-2-methylpropionanilide
|
|
22 |
|
Tetracaine |
Approved, Vet_approved |
|
|
94-24-6 |
5411 |
Synonyms:
2-(DIMETHYLAMINO)ETHYL 4-(BUTYLAMINO)BENZOATE
2-(Dimethylamino)ethyl 4-(butylamino)benzoic acid
2-(Dimethylamino)ethyl p-(butylamino)benzoate
2-(Dimethylamino)ethyl p-(butylamino)benzoic acid
Amethocaine
AMETHOCAINE HCL
Ametop
Diaethylaminoaethanol ester der p-butylaminobenzoesaeure
DIÄTHYLAMINOÄTHANOL ESTER DER P-BUTYLAMINOBENZÖSÄURE
Dicaine
Hydrochloride, tetrracaine
MEDIHALER-TETRACAINE
METRASPRAY
p-(Butylamino)benzoate b-(dimethylamino)ethyl ester
p-(Butylamino)benzoate beta-(dimethylamino)ethyl ester
p-(Butylamino)benzoate β-(dimethylamino)ethyl ester
|
p-(Butylamino)benzoic acid b-(dimethylamino)ethyl ester
p-(Butylamino)benzoic acid beta-(dimethylamino)ethyl ester
p-(Butylamino)benzoic acid β-(dimethylamino)ethyl ester
Pantocaine
p-Butylaminobenzoyl-2-dimethylaminoethanol
Pontocaine
TET150
Tetracaina
TETRACAÍNA
TETRACAINE
TÉTRACAÏNE
TETRACAINE HCL
Tetracaine monohydrochloride
Tetracainum
Tetrakain
Tetrracaine hydrochloride
|
|
23 |
|
Chlorhexidine |
Approved, Vet_approved, Withdrawn |
|
|
55-56-1 |
2713 9552079 |
Synonyms:
1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide)
AVAGARD
CHLORHEXIDIN
CHLORHEXIDIN [CZECH]
CHLORHEXIDINE
CHLORHEXIDINUM
CHLORHEXIDINUM [INN-LATIN]
Cloresidina
CLORESIDINA [DCIT]
CLORHEXIDINA
CLORHEXIDINA [INN-SPANISH]
|
Dentisept
EXIDINE
HIBISTAT
Merfen-incolore
N-(4-CHLOROPHENYL)-1-3-(6-{N-[3-(4-CHLOROPHENYL)CARBAMIMIDAMIDOMETHANIMIDOYL]AMINO}HEXYL)CARBAMIMIDAMIDOMETHANIMIDAMIDE
N,N'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
NOLVASAN
PERIDEX
STERILON
SUTHOL
SUTHOOOL
|
|
24 |
|
Hormones |
|
|
|
|
|
25 |
|
Hormone Antagonists |
|
|
|
|
|
26 |
|
glucocorticoids |
|
|
|
|
|
27 |
|
Anti-Inflammatory Agents |
|
|
|
|
|
28 |
|
Anti-Bacterial Agents |
|
|
|
|
|
29 |
|
Antibiotics, Antitubercular |
|
|
|
|
|
30 |
|
Sunscreening Agents |
|
|
|
|
|
31 |
|
Emollients |
|
|
|
|
|
32 |
|
Mitogens |
|
|
|
|
|
33 |
|
Anti-Arrhythmia Agents |
|
|
|
|
|
34 |
|
Sodium Channel Blockers |
|
|
|
|
|
35 |
|
Anesthetics, Local |
|
|
|
|
|
36 |
|
Anesthetics |
|
|
|
|
|
37 |
|
Diuretics, Potassium Sparing |
|
|
|
|
|
38 |
|
Chlorhexidine gluconate |
|
|
|
|
|
39 |
|
Dermatologic Agents |
|
|
|
|
|
Interventional clinical trials:
(show all 40)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Photodynamic Therapy for Melanoma Precursor Lesion Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion (BF-200 ALA) as a Light Sensitizing Cream |
Completed |
NCT02685592 |
Phase 4 |
5-aminolevulinic acid nanoemulsion |
2 |
Effect of Topical Imiquimod on Lentigo Maligna |
Completed |
NCT01161888 |
Phase 4 |
Imiquimod |
3 |
Use of TCA 15% + 3% Glycolic Acid Chemical Peel for Improvement in Hand Lentigines |
Not yet recruiting |
NCT05471947 |
Phase 4 |
15% Trichloroacetic acid + 3% glycolic acid |
4 |
An Open Monocentric Pilot Study to Investigate the Potential of Imiquimod 5% Cream to Detect Residual and to Prevent Recurrence of Lentigo Maligna After Surgical Excision |
Unknown status |
NCT01088737 |
Phase 2, Phase 3 |
Imiquimod |
5 |
Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face |
Completed |
NCT01720407 |
Phase 3 |
Imiquimod cream + surgery;Placebo + surgery |
6 |
A Randomised Controlled Multicentre Trial of Imiquimod Versus Radiotherapy for Lentigo Maligna (LM) When Staged Surgical Excision With 5mm Margins is Not Possible, is Refused, or Fails |
Active, not recruiting |
NCT02394132 |
Phase 3 |
Imiquimod |
7 |
Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face - Study PICAMEL |
Unknown status |
NCT02723721 |
Phase 2 |
Picato gel |
8 |
Efficacy and Side Effects of Q-Switched Ruby Laser Treatment of Solar Lentigines in Two Different Fitzpatrick Skin Types II and IV |
Completed |
NCT00386204 |
Phase 2 |
|
9 |
Solar Lentigines Treatment With the Triple Combination Cream (Hydroquinone 4%, Tretinoin 0.05%, and Fluocinolone Acetonide 0.01%). Randomized, Double Blind, Controlled Trial. |
Completed |
NCT00975312 |
Phase 2 |
Triple combination cream;Tretinoin 0.05% |
10 |
A Phase II Study of AZD2171 in Previously Untreated Patients With Metastatic or Recurrent Malignant Melanoma |
Completed |
NCT00243061 |
Phase 2 |
cediranib maleate |
11 |
A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma |
Active, not recruiting |
NCT00937937 |
Phase 2 |
Dinaciclib |
12 |
Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma |
Terminated |
NCT01120275 |
Phase 2 |
gamma-secretase/Notch signalling pathway inhibitor RO4929097 |
13 |
Evaluate the Lightening Effect of the Whitening Cosmetic Product BEX-2011 on Solar Lentigines by Harmonic Generation Microscopy |
Unknown status |
NCT01249469 |
|
|
14 |
Advanced Harmonic Generation Microscopy for Treatment Assessment of Cutaneous Pigmentary Disorder |
Unknown status |
NCT03578315 |
|
|
15 |
Clinical, Histological and Biochemical Characterization of Hyperpigmented Lesion. |
Unknown status |
NCT01136629 |
|
|
16 |
Safety and Efficacy of Cutera Picosecond Q-Switched Nd:YAG Laser in the Treatment of Solar Lentigines |
Completed |
NCT01885871 |
|
|
17 |
A Single Center, Randomized, Double-blind and Placebo Controlled Clinical Study to Evaluate the Efficacy and Safety of Brightening Micro-needle Patch on Facial Solar Lentigines |
Completed |
NCT04583852 |
|
|
18 |
A Single-Center 2-Arm Study of the Enlighten and Excel V Laser for Lentigines on the Hands |
Completed |
NCT02763072 |
|
|
19 |
Study for the RevLite Laser System for Facial Solar Lentigines |
Completed |
NCT02110108 |
|
|
20 |
Effect of Topical Corticosteroids on the Incidence of Postinflammatory Hyperpigmentation Following Q-switched Nd:YAG 532 nm Laser for Treatment of Facial Lentigines - A Pilot Study |
Completed |
NCT02492373 |
|
topical 0.05% Clobetasol propionate ointment |
21 |
A Prospective Multi-Center Study of a Novel Dual-Wavelength, Dual-Pulse Duration Laser for the Treatment of Melasma and Lentigines in Asian Skin |
Completed |
NCT02385994 |
|
|
22 |
Safety and Efficacy of a Triple Combination Cream as Adjuvant Treatment of Solar Lentigines With Cryotherapy. |
Completed |
NCT01778179 |
|
Tri-luma |
23 |
Comparative Study Investigating the Therapy of of Solar Lentigines With the Q-switched SINON Rubin 694nm Laser Versus Pigmanorm® Cream |
Completed |
NCT02153697 |
|
Pigmanorm Cream |
24 |
A Randomized Controlled Trial on the Effectiveness of Epidermal Growth Factor-containing Ointment on the Treatment of Solar Lentigines as Adjuvant Therapy |
Completed |
NCT04704245 |
|
epidermal growth factor (EGF)-containing ointment;Vehicle ointment |
25 |
Prospective Clinical Trial to Assess the Performance of a Cyto-selective Cryotherapye "CRYOBEAUTY MAINS ET DECOLLETE" Compared With Liquid Nitrogen Cryotherapy in the Treatment of Solar Lentigines in 30 Patients |
Completed |
NCT03225729 |
|
|
26 |
Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna |
Completed |
NCT00707174 |
|
Imiquimod Cream;Tazarotene Cream 0.1% |
27 |
Reflectance Confocal Microscopy to Diagnose Malignant Melanoma and Lentigo Maligna |
Completed |
NCT03508297 |
|
|
28 |
Efficacy and Tolerance of D-pigment Versus Moisturizer in Hands' Lentigo Lesions With or Without Laser Therapy |
Completed |
NCT03457246 |
|
|
29 |
In Vivo Reflectance Confocal Microscopy for Pigmented Lesion Diagnosis: A Multi-center Study |
Completed |
NCT00785369 |
|
|
30 |
Evaluation of the Tolerance of Cyto-selective Difluoroethane-based Cryotherapy |
Completed |
NCT05322668 |
|
|
31 |
Clinical Evaluation of the Performance of a Difluoroethane-based Cyto-selective Cryotherapy to Treat Dark Spots on the Hand in 30 Volunteers. |
Completed |
NCT03157427 |
|
|
32 |
Evaluation of the Tolerance and the Mode of Administration of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots |
Completed |
NCT05203263 |
|
|
33 |
Evaluation of the Tolerance and the Mode of Administration of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots |
Completed |
NCT05014321 |
|
|
34 |
Investigation Into the Natural History and Metabolic and Molecular Basis of RASopathies. |
Recruiting |
NCT04395495 |
|
|
35 |
The Effect of Topical Anesthetic Using Lidocaine 2.5%/Prilocaine 2.5% Versus Lidocaine 7%/Tetracaine 7% Cream on Patients' Pain and Operative Experience During Treatment With QSwitched 532nm Laser |
Active, not recruiting |
NCT02427724 |
|
lidocaine 2.5%/prilocaine 2.5% topical anesthetic;lidocaine 7%/tetracaine 7% topical anesthetic;placebo vehicle |
36 |
Evaluation of the Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post-inflammatory Hyperpigmentation) |
Not yet recruiting |
NCT05625815 |
|
|
37 |
MRB 0.3% Serum Effectiveness on 2 Early Clinical Markers of Photoinduced Cutaneous Aging: Actinic Lentigo and Actinic Keratosis A Single-center Clinical Study in Two Phases: First Phase: Randomized Double-blind Clinical Interventional Study Versus Placebo in Split Face or Split Skull Second Phase: Open-label Observational Clinical Study on the Entire Face or Skull |
Not yet recruiting |
NCT05152407 |
|
|
38 |
Evaluation of the Tolerance and Performance (Mode of Administration) of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots |
Not yet recruiting |
NCT05600049 |
|
|
39 |
Comparative Study of Electrical Impedance Spectroscopy (EIS) Models Against Verified Dermatological Diagnostic Data |
Suspended |
NCT04688749 |
|
|
40 |
Mohs Micrographic Surgery for Primary Cutaneous Malignant Melanoma In Situ Using Immunofluorescence |
Withdrawn |
NCT02306512 |
|
|
|